| 1. |
Gigante E, Paradis V, Ronot M, et al. New insights into the pathophysiology and clinical care of rare primary liver cancers. JHEP Rep, 2020, 3(1): 100174. doi: 10.1016/j.jhepr.2020.100174.
|
| 2. |
Kou K, Chen YG, Zhou JP, et al. Hepatic epithelioid hemangioendothelioma: update on diagnosis and therapy. World J Clin Cases, 2020, 8(18): 3978-3987.
|
| 3. |
Liu Z, Yi L, Chen J, et al. Comparison of the clinical and MRI features of patients with hepatic hemangioma, epithelioid hemangioendothelioma, or angiosarcoma. BMC Med Imaging, 2020, 20(1): 71. doi: 10.1186/s12880-020-00465-4.
|
| 4. |
Virarkar M, Saleh M, Diab R, et al. Hepatic hemangioendothelioma: an update. World J Gastrointest Oncol, 2020, 12(3): 248-266.
|
| 5. |
Onishi Y, Kusumoto M, Motoi N, et al. Natural history of epithelioid hemangioendothelioma of the liver: CT findings of 15 cases. Acad Radiol, 2021, 28(6): 778-782.
|
| 6. |
Cieszanowski A, Anysz-Grodzicka A, Podgorska J, et al. Magnetic resonance imaging of uncommon hepatic mesenchymal tumours: haemangioendothelioma and angiosarcoma. Curr Med Imaging Rev, 2019, 15(4): 362-368.
|
| 7. |
Mamone G, Miraglia R. The “Target sign” and the “Lollipop sign” in hepatic epithelioid hemangioendothelioma. Abdom Radiol (NY), 2019, 44(4): 1617-1620.
|
| 8. |
Dong K, Wang XX, Feng JL et al. Pathological characteristics of liver biopsies in eight patients with hepatic epithelioid hemangioendothelioma. Int J Clin Exp Pathol, 2015, 8(9): 11015-11023.
|
| 9. |
Hsieh MS, Liang PC, Kao YC, et al. Hepatic epithelioid hemangioendothelioma in Taiwan: a clinicopathologic study of six cases in a single institution over a 15-year period. J Formos Med Assoc, 2010, 109(3): 219-227.
|
